RogelioMosqueda-GarciaMDPh.D.

PubMed

• 8 citations
  Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects
  Richard D. Finkelman, Tzung-Dau Wang, Yi Wang, Connie T. Azumaya, Bruce K. Birmingham
  Clinical Pharmacology in Drug Development. 2015-01-01
• 222 citations
  Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
  Charles Frost, Sunil Nepal, Jessie Wang, Alan Schuster, Wonkyung Byon
  British Journal of Clinical Pharmacology. 2013-11-01
• 273 citations
  Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
  Charles Frost, Jessie Wang, Sunil Nepal, Alan Schuster, Yu Chen Barrett
  British Journal of Clinical Pharmacology. 2013-02-01

Journal Articles

• Role of CYP2C19 polymorphism in the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects  
  Wang Y. Wang T-D, Finkelman R.D, Jou1 H-C, Azumaya C.T, Mosqueda-Garcia R,, Clin Pharmacol Drug Development, 2014
• Apixaban, an oral, direct factor-Xa inhibitor: single-dose safety, pharmacokinetics, and pharmacodynamics  
  Frost C, Wang J, Nepal S, Schuster A, Chen Barrett Y, Reeves RA,, LaCreta F, Mosqueda-Garcia R, Bri J Clin Pharm. 2013;75:476-487, 2013
• The elusive pathophysiology of neurally mediated syncope.  
  Mosqueda-Garcia R, Medina E, Fernandez-Violante R., Circulation, 2000
• Chronic orthostatic intolerance: a primary central sympathetic disorder with discordant cardiac and vascular sympathetic control  
  Furlan R, Jacob G, Snell M, Porta A, Robertson D, Harris P, Mosqueda-Garcia R., Circulation, 1998
• Yohimbine in neurally mediated syncope: pathophysiological implications.  
  Mosqueda-Garcia R, Fernandez-Violante R, Snell M, Cunningham G, Furlan R., J Clin Invest, 1998
• Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal man.  
  Davis S.N, Shavers C, Costa F, Mosqueda-Garcia R., Diabetes, 1997
• Sympathetic and baroreceptor reflex function in neurally-mediated syncope evoked by tilt.  
  Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, Ananthram V, Robertson RM, Robertson D., J Clin Invest, 1997
• Role of cortisol in the pathogenesis of deficient counterregulation following antecedent hypoglycemia in normal humans.  
  Davis S.N, Shavers C, Costa F, Mosqueda-Garcia R., J Clin Invest, 1996
• Clinical models of cardiovascular regulation after weightlessness.  
  Robertson D, Jacob G, Ertl A, Shanon J, Mosqueda-Garcia R, Robertson RM,, Med Sci Sports Exerc, 1996
• The diagnosis and treatment of baroreflex failure.  
  Robertson D, Hollister AS, Netterville JL, Mosqueda-Garcia R, Robertson RM, New Engl J Med, 1993
• Guanfacine: A second generation of α2-adrenergic blocker  
  Mosqueda-Garcia R., Am J Med Sci, 1990
• Opiate receptors and the endorphin-mediated cardiovascular effects of clonidine in rats: evidence for hypertension-induced μ-subtype to δ-subtype changes  
  Mosqueda-Garcia R, Kunos G., Proc Natl Acad Sci USA, 1987
• Beta-endorphin in central cardiovascular control.  
  Mosqueda-Garcia R., Cardiovasc Rev Rep, 1987
• Join now to see all

Books/Book Chapters

• Vasovagal Syncope 
  Chapter: Pathophysiology of Vasovagal Syncope: Role of Baroreceptor Mechanisms 
  Mosqueda-Garcia REditors: Furlan R, Alboni P.Springer Verlag , Milan
• Vasovagal Syncope 
  Chapter: Role of the autonomic nervous system in vasovagal syncope 
  Mosqueda-Garcia REditors: Furlan R, Alboni P.Springer Verlag , Milan2014
• Primer on the Autonomic Nervous System 
  Chapter: Central Cardiovascular Control 
  Page 3 - 12Mosqueda-Garcia REditors: Robertson D, Low P, Polinsky RJ.Academic Press, San Diego1996
• Disorders of the Autonomic Nervous System 
  Chapter: Evaluation of autonomic failure 
  Page 25 - 60Mosqueda-Garcia R.Editors: Burnstock G.Harwood Academic Publishers, Luxembourg1995
• Hypertension: Pathology, Diagnosis & Management 
  Chapter: Adenosine in cardiovascular homeostasis and the pharmacologic control of its activity 
  Page 1125 - 1140Biaggioni I, Mosqueda-Garcia REditors: Laragh JH, Brenner BM.Raven Press, New York1995
• Join now to see all

Lectures

• Safety Evaluation in Clinical Pharmacology and Experimental Medicine Studies. Are Changes Needed?" 
  Thomas Jefferson University. School of Medicine - 12/9/2008
• 36. Safety in Phase I; Changes & lessons from the Tegenero (TGN1412) Experience 
  AstraZeneca Clinical Pharmacology Series - 8/31/2006
• The elusive pathophysiology of neurally mediated syncope 
  Hospital Sacco. Milan Italy - 6/18/1999
• Decreased Reflex Sympathetic Function in Neurally Mediated Syncope: Requiem for the Ventricular Theory? 
  National Heart, Lung and Blood Institute, Bethesda, Maryland - 4/3/1997
• Central Cardiovascular Effects of Endothelin. 
  Department of Pharmacology, Medical College of Virginia, Richmond Virginia, - 12/11/1995
• Evaluation of neural sympathetic function in man 
  Universidad Americana de Acapulco. Mexican Society of Physiological Sciences, - 8/19/1993
• Effects of caffeine on the cardiovascular system 
  Pharmacology Institute "Mario Negri". Milan Italy, - 1/1992
• Purinergic regulation of arterial blood pressure: Basic and clinical studies 
  University of Montreal, Department of Physiology, - 10/1991
• Adenosine in central cardiovascular control 
  National Heart, Lung and Blood Institute, Bethesda, Maryland - 5/1990
• The Role of Beta-Endorphin in Central Cardiovascular Control 
  National Heart, Lung and Blood Institute, Bethesda, Maryland - 4/1987
• Importance of the Brain Beta-Endorphin System in the Cardiovascular Effects of Clonidine 
  Nippon Press Center, Tokyo, Japan - 10/1985
• Beta-Endorphin: Possible Involvement in the Antihypertensive Effect of Central Alpha Receptor Activation. 
  Douglas Research Hospital, Montreal, Canada - 4/1984
• Join now to see all